Evidence map›Paper›PMID 38721749›Full record

ArticleHaematologica2024

Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.

Yoshiko Atsuta, Helen Baldomero, Daniel Neumann, Anna Sureda, Jakob D DeVos, Minako Iida, Amado Karduss, Duncan Purtill, Alaa M Elhaddad, Nosa G Bazuaye and 37 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute. y-atsuta@jdchct.or.jp.
Helen BaldomeroThe Worldwide Network of Blood and Marrow Transplantation (WBMT) Transplant Activity Survey Office, University Hospital, Basel, CH.
Daniel NeumannInstitute of Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig.
Anna SuredaClinical Hematology Department, Institut Català d'Onvcologia - L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona.
Jakob D DeVosCenter for International Blood and Marrow Transplant Resaerch, Medical College of Wisconsin, Milwaukee, Wisconsin.
Minako IidaDepartment of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute.
Amado KardussInstituto de Cancerología-Clínica Las Américas, Medellín, Colombia.
Duncan PurtillHaematology Department, Fiona Stanley Hospital, Murdoch, Australia.
Alaa M ElhaddadDepartment of Pediatric Oncology and Stem Cell Transplantation Unit, Cairo University Cairo, Egypt.
Nosa G BazuayeDepartment of Hematology and Blood Transfusion, University of Benin Teaching Hospital, Edo State, Nigeria.
Carmem BonfimPele Pequeno Principe Research Institute/ Pediatric Blood and Marrow Transplantation Program Hospital Pequeno Principe, Curitiba, Brazil.
Rafael De la CamaraHematology Department, Hospital de la Princesa, Madrid.
Naeem A ChaudhriOncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Fabio CiceriOspedale San Raffaele s.r.l., Haematology and BMT, Milano.
Cinthya CorreaHospital Israelita Albert Eisntein, Sao Paula Brazil.
Cristobal FrutosInstituto de Previsión Social, Asunción, Paraguay.
Sebastian GaleanoHospital Británico, Montevideo, Uruguay.
Laurent GarderetSorbonne Université, Service d'Hématologie et thérapie cellulaire, HôpitalPitié Salpêtrière, AP-HP, Paris, France .
Oscar Gonzalez-RamellaHospital Civil de Guadalajara, Dr Juan I Menchaca, Guadalajara, Mexico.
Raffaella GrecoUnit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Milan.
Nada HamadHaematology Clinical Research Unit, St. Vincent's Health Network, Kinghorn Cancer Centre, Sydney, Australia.
Mette D HazenbergDepartment of Hematology, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam.
Mary M HorowitzCenter for International Blood and Marrow Transplant Resaerch, Medical College of Wisconsin, Milwaukee, Wisconsin.
Krzysztof KalwakDepartment of Pediatric Hematology, Oncology and BMT, Wroclaw Medical University, Wroclaw.
Bor-Sheng KoDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Yoshihisa KoderaDepartment of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute.
Mickey Bc KohInstitute for Infection and Immunity St. George's Hospital and Medical School, University of London, London.
Kaiyan LiuDepartment of Hematology, Peking University Institute of Hematology, Beijing.
Donal P McLornanDepartment of Haematology, University College Hospital, London.
Joon Ho MoonDivision of Hematology-Oncology, Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea.
Benedicte NevenService d'immunologie-Hématologie Et Rhumatologie Pédiatrique, Hôpital Necker-Enfants Malades, Assistance Publique des Hôpitaux de Paris, INSERM, Paris.
Shinichiro OkamotoDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo.
Marcelo C PasquiniCenter for International Blood and Marrow Transplant Resaerch, Medical College of Wisconsin, Milwaukee, Wisconsin.
Jakob R PasswegThe Worldwide Network of Blood and Marrow Transplantation (WBMT) Transplant Activity Survey Office, University Hospital, Basel, CH.
Kristjan PaulsonSection of Haematology/Oncology, Department of Internal Medicine, Max Rady College of Medicine, the University of Manitoba, Winnipeg, Manitoba, Canada.
Damiano RondelliDivision of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL.
Annalisa RuggeriHematology and BMT Unit, San Raffaele Scientific Institute, Milano.
Adriana SeberDepartment of Medicine, Universidade Federal de Sao Paulo Escola Paulista de Medicina: Sao Paulo, Brazil.
John A SnowdenDepartment of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
Alok SrivastavaDepartment of Hematology, Christian Medical College Hospital, Vellore.
Jeff SzerClinical Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Daniel WeisdorfDivision of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Nina WorelDepartment of Transfusion Medicine and Cell Therapy, Medical University of Vienna, Vienna.
Hildegard GreinixDivision of Hematology, Medical University of Graz, Graz.
Wael SaberCenter for International Blood and Marrow Transplant Resaerch, Medical College of Wisconsin, Milwaukee, Wisconsin.
Mahmoud AljurfOncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Dietger NiederwieserDivision of Hematology and Medical Oncology, University of Leipzig, Leipzig.

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
NCI NIH HHS U24 CA076518
6 · The paper itself

Abstract

Promoting access to and excellence in hematopoietic cell transplantation (HCT) by collecting and disseminating data on global HCT activities is one of the principal activities of the Worldwide Network for Blood and Marrow Transplantation, a non-governmental organization in working relations with the World Health Organization. HCT activities are recorded annually by member societies, national registries and individual centers including indication, donor type (allogeneic/autologous), donor match and stem cell source (bone marrow/peripheral blood stem cells/cord blood). In 2018, 1,768 HCT teams in 89 countries (6 World Health Organization regions) reported 93,105 (48,680 autologous and 44,425 allogeneic) HCT. Major indications were plasma cell disorders and lymphoma for autologous, and acute leukemias and MDS/MPN for allogeneic HCT. HCT numbers increased from 48,709 in 2007. Notable increases were seen for autoimmune diseases in autologous and hemoglobinopathies in allogeneic HCT. The number of allogeneic HCT more than doubled with significant changes in donor match. While HCT from HLA-identical siblings has seen only limited growth, HCT from non-identical related donors showed significant increase worldwide. Strongest correlation between economic growth indicator of gross national income/capita and HCT activity/10 million population was observed for autologous HCT (correlation coefficient [r]=0.79). HCT from unrelated donors showed strong correlation (r=0.68), but only moderate correlation was detected from related donors (r=0.48 for HLA-identical sibling; r=0.45 for other). The use of HCT doubled in about a decade worldwide at different speed and with significant changes regarding donor match as a sign of improved access to HCT worldwide. Although narrowing, significant gaps remain between developing and non-developing countries.

Indexed as

Hematopoietic Stem Cell TransplantationUnrelated DonorsGlobal HealthHealth Services AccessibilityHumansRegistriesTissue Donors

Identifiers

PMID38721749
PMCPMC11443380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.